254 related articles for article (PubMed ID: 1645741)
1. Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma.
Dowdy SF; Weissman BE; Stanbridge EJ
J Cell Physiol; 1991 May; 147(2):248-55. PubMed ID: 1645741
[TBL] [Abstract][Full Text] [Related]
2. Suppression of tumorigenicity of a Wilms' tumor cell line is associated with a decrease in synthesis of two proteins.
Wheeler TT; Xiao JP; Dowdy SF; Stanbridge EJ; Young DA
Oncogene; 1991 Oct; 6(10):1903-7. PubMed ID: 1656366
[TBL] [Abstract][Full Text] [Related]
3. Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines.
Oshimura M; Kugoh H; Koi M; Shimizu M; Yamada H; Satoh H; Barrett JC
J Cell Biochem; 1990 Mar; 42(3):135-42. PubMed ID: 2318911
[TBL] [Abstract][Full Text] [Related]
4. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080.
Kugoh HM; Hashiba H; Shimizu M; Oshimura M
Oncogene; 1990 Nov; 5(11):1637-44. PubMed ID: 2267132
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tumorigenicity and induction of senescence on human endometrial carcinoma cell lines by transfer of normal human chromosomes.
Yamada H
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1443-54. PubMed ID: 7705753
[TBL] [Abstract][Full Text] [Related]
6. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
7. Multiple chromosomes carrying tumor suppressor activity for a uterine endometrial carcinoma cell line identified by microcell-mediated chromosome transfer.
Yamada H; Wake N; Fujimoto S; Barrett JC; Oshimura M
Oncogene; 1990 Aug; 5(8):1141-7. PubMed ID: 2392323
[TBL] [Abstract][Full Text] [Related]
8. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line.
Lamonerie T; Lavialle C; de Galle B; Binoux M; Brison O
Exp Cell Res; 1995 Feb; 216(2):342-51. PubMed ID: 7531153
[TBL] [Abstract][Full Text] [Related]
9. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
10. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
Klinger HP; Shows TB
J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
[TBL] [Abstract][Full Text] [Related]
11. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
[TBL] [Abstract][Full Text] [Related]
12. Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2.
Rider MA; Butz GM; Ricketts SL; Newberry ST; Grisham JW; Coleman WB
Int J Oncol; 2002 Feb; 20(2):235-45. PubMed ID: 11788883
[TBL] [Abstract][Full Text] [Related]
13. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
[TBL] [Abstract][Full Text] [Related]
14. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
15. Re-expression of tumorigenicity after attenuation of human synaptotagmin 13 in a suppressed microcell hybrid cell line.
Jahn JE; Coleman WB
Int J Oncol; 2008 Feb; 32(2):441-9. PubMed ID: 18202767
[TBL] [Abstract][Full Text] [Related]
16. Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.
Schiller JH; Bittner G
Cancer Res; 1995 Dec; 55(24):6215-21. PubMed ID: 8521416
[TBL] [Abstract][Full Text] [Related]
17. Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells.
Fraizer GE; Bowen-Pope DF; Vogel AM
J Cell Physiol; 1987 Oct; 133(1):169-74. PubMed ID: 2444606
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
19. The isolation and characterization of a novel cDNA demonstrating an altered mRNA level in nontumorigenic Wilms' microcell hybrid cells.
Dowdy SF; Lai KM; Weissman BE; Matsui Y; Hogan BL; Stanbridge EJ
Nucleic Acids Res; 1991 Oct; 19(20):5763-9. PubMed ID: 1658743
[TBL] [Abstract][Full Text] [Related]
20. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression.
Weissman BE; Saxon PJ; Pasquale SR; Jones GR; Geiser AG; Stanbridge EJ
Science; 1987 Apr; 236(4798):175-80. PubMed ID: 3031816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
